These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28479897)

  • 1. Socio-demographic correlates of treatment response among patients with schizophrenia in a tertiary hospital in South-East Nigeria.
    Ezeme MS; Uwakwe R; Ndukuba AC; Igwe MN; Odinka PC; Amadi K; Obayi NO
    Afr Health Sci; 2016 Dec; 16(4):1036-1044. PubMed ID: 28479897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Correlates of Treatment Response among Patients with Schizophrenia in a Tertiary Nigerian Hospital.
    Ezeme MS; Uwakwe R; Ndukuba AC; Igwe MN; Odinka PC; Amadi K; Obayi NO
    J Health Care Poor Underserved; 2017; 28(2):721-738. PubMed ID: 28529220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-Demographic Characteristics, Partner Characteristics, Socioeconomic Variables, and Intimate Partner Violence in Women with Schizophrenia in South-South Nigeria.
    Afe TO; Emedoh TC; Ogunsemi OO; Adegohun AA
    J Health Care Poor Underserved; 2017; 28(2):707-720. PubMed ID: 28529219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and socio-demographic profile of patients with schizophrenia according to the antipsychotic treatment prescribed].
    Lamarque I; Auffray L; Villamaux M; Demant JC; Launay C; Petitjean F; Salomé F
    Encephale; 2006; 32(3 Pt 1):369-76. PubMed ID: 16840931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to second generation antipsychotics in drug naïve patients with schizophrenia: a 1 year follow-up study in Shanghai.
    Zhang HX; Shen XL; Zhou H; Yang XM; Wang HF; Jiang KD
    Psychiatry Res; 2014 Jan; 215(1):20-5. PubMed ID: 24230993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].
    Bouhlel S; M'solly M; Benhawala S; Jones Y; El-Hechmi Z
    Encephale; 2013 Feb; 39(1):6-12. PubMed ID: 23095582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREVALENCE AND PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIA IN MAIDUGURI, NORTHEASTERN NIGERIA.
    Shettima F; Sheikh T; Wakil M; Wakama I; Abdulaziz M; Rabbebe I
    West Afr J Med; 2023 Nov; 40(11 Suppl 1):S21-S22. PubMed ID: 37976234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
    Bugarski-Kirola D; Iwata N; Sameljak S; Reid C; Blaettler T; Millar L; Marques TR; Garibaldi G; Kapur S
    Lancet Psychiatry; 2016 Dec; 3(12):1115-1128. PubMed ID: 27816567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia.
    Bolstad A; Andreassen OA; Røssberg JI; Agartz I; Melle I; Tanum L
    BMC Psychiatry; 2011 Aug; 11():126. PubMed ID: 21812996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics.
    Chen YL; Chen KP; Chiu CC; Tai MH; Lung FW
    BMC Psychiatry; 2018 Dec; 18(1):376. PubMed ID: 30509308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.
    Lambert M; Holzbach R; Moritz S; Postel N; Krausz M; Naber D
    Int Clin Psychopharmacol; 2003 Sep; 18(5):251-60. PubMed ID: 12920385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Work functioning of schizophrenia patients in a rural south Indian community: status at 4-year follow-up.
    Suresh KK; Kumar CN; Thirthalli J; Bijjal S; Venkatesh BK; Arunachala U; Kishorekumar KV; Subbakrishna DK; Gangadhar BN
    Soc Psychiatry Psychiatr Epidemiol; 2012 Nov; 47(11):1865-71. PubMed ID: 22419163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.